Niosomes based formulation containing tenoxicam: A newer solution for the rheumatic diseases

Pandey, 2019, Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal-and photodynamic-therapy of rheumatoid arthritis, J Colloid Interface Sci, 544, 61, 10.1016/j.jcis.2019.02.073 Ceribelli, 2020, Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy, J Autoimmun, 109, 102442, 10.1016/j.jaut.2020.102442 Hyrich, 2021, Rheumatic disease and COVID-19: epidemiology and outcomes, Nat Rev Rheumatol, 17, 71, 10.1038/s41584-020-00562-2 Grainger, 2022, COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations, Nat Rev Rheumatol, 18, 191, 10.1038/s41584-022-00755-x Mikuls, 2020, American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 2, Arthritis Rheumatol, 72, e1 Rubin, 2019, B cell checkpoints in autoimmune rheumatic diseases, Nat Rev Rheumatol, 15, 303, 10.1038/s41584-019-0211-0 Hyrich, 2023, Response to: “Correspondence on Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry” by Rosenbaum et al, Ann Rheum Dis, 82, e139, 10.1136/annrheumdis-2021-220613 Bossuyt, 2020, Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases, Nat Rev Rheumatol, 16, 715, 10.1038/s41584-020-00522-w Shin, 2019, Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review, J Autoimmun, 103, 102299, 10.1016/j.jaut.2019.06.010 Staud, 2022, Advances in the management of fibromyalgia: what is the state of the art?, Expert Opin Pharmacother, 23, 979, 10.1080/14656566.2022.2071606 Elakkad, 2021, Tenoxicam loaded hyalcubosomes for osteoarthritis, Int J Pharm, 601, 120483, 10.1016/j.ijpharm.2021.120483 Zabihi, 2021, Tenoxicam (Mobiflex) solubility in carbon dioxide under supercritical conditions, J Chem Eng Data, 66, 990, 10.1021/acs.jced.0c00816 Hussein, 2022, Tenoxicam-loaded polymeric micelles material: Formulation, optimization, and evaluation, Mater Today Proc, 61, 672, 10.1016/j.matpr.2021.08.218 Maggi, 2023, Hybrid nanocomposites of tenoxicam: layered double hydroxides (LDHs) vs. Hydroxyapatite (HAP) inorganic carriers, Molecules, 28, 4035, 10.3390/molecules28104035 Osman, 2023, A novel approach for the availability and ocular delivery of tenoxicam potassium: synthesis, characterization, and in vivo application, AAPS, Pharm Sci Tech, 24, 44, 10.1208/s12249-022-02487-3 Xie, 2022, Insight into the formation of cocrystal and salt of tenoxicam from the isomer and conformation, Pharmaceutics, 14, 1968, 10.3390/pharmaceutics14091968 García-Rayado, 2018, NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs, Expert Rev Clin Pharmacol, 11, 1031, 10.1080/17512433.2018.1516143 Singhai, 2020, CD44 receptor targeted ‘smart’multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer, Colloid Interface Sci Commun, 35, 100235, 10.1016/j.colcom.2020.100235 Kapoor, 2022, Quality-by-design-based engineered liposomal nanomedicines to treat cancer: an in-depth analysis, Nanomedicine, 17, 1173, 10.2217/nnm-2022-0069 Singhai, 2020, Chondroitin sulphate and α-tocopheryl succinate tethered multiwalled carbon nanotubes for dual-action therapy of triple-negative breast cancer, J Drug Deliv Sci Technol, 60, 102080, 10.1016/j.jddst.2020.102080 Singhai, 2023, New insights in aptamer-targeted nanoliposomes for the treatment of breast cancer, J Drug Deliv Sci Technol, 87, 104880, 10.1016/j.jddst.2023.104880 Mishra, 2019, Cutaneous and transdermal drug delivery: techniques and delivery systems, 595 Tekade, 2017, Biopolymer-based nanocomposites for transdermal drug delivery, 81 Todke, 2022, ‘Transfersome-embedded-gel’ for dual-mechanistic delivery of anti-psoriatic drugs to dermal lymphocytes, J Microencapsul, 39, 495, 10.1080/02652048.2022.2116119 Chatterjee, 2019, Dual-responsive (pH/temperature) Pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy, Sci Rep, 9, 11658, 10.1038/s41598-019-48254-6 Chatterjee, 2020, Drug delivery system of dual-responsive PF127 hydrogel with polysaccharide-based nano-conjugate for textile-based transdermal therapy, Carbohydr Polym, 236, 116074, 10.1016/j.carbpol.2020.116074 Shah, 2020, Enhancement in antinociceptive and anti-inflammatory effects of tramadol by transdermal proniosome gel, Asian J Pharm Sci, 15, 786, 10.1016/j.ajps.2019.05.001 Akbari, 2022, Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration, Pharm Dev Technol, 27, 525, 10.1080/10837450.2022.2084554 Attia, 2022, Iron oxide nanoparticles and their pharmaceutical applications, Appl Surface Sci Adv, 11, 100284, 10.1016/j.apsadv.2022.100284 Khalaf, 2023, Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review, Int J Biol Macromol, 231, 123354, 10.1016/j.ijbiomac.2023.123354 Sharmin, 2022, Highly efficient photocatalytic degradation of hazardous industrial and pharmaceutical pollutants using gadolinium doped BiFeO3 nanoparticles, J Alloys Compd, 901, 163604, 10.1016/j.jallcom.2021.163604 Kapoor, 2021, Pharmaceutical and Biomedical Applications of Multifunctional Quantum Dots, 65 Mahajan, 2020, NanoGold-core dendrimeric seeds for combined chemo-, photothermal-, and photodynamic therapy of cancer, J Drug Deliv Sci Technol, 58, 101814, 10.1016/j.jddst.2020.101814 Maheshwari, 2022, Laser activatable nanographene colloids for chemo-photothermal combined gene therapy of triple-negative breast cancer, Biomater Adv, 133, 112605, 10.1016/j.msec.2021.112605 Aparajay, 2022, Functionalized niosomes as a smart delivery device in cancer and fungal infection, Eur J Pharm Sci, 168, 106052, 10.1016/j.ejps.2021.106052 Haddadian, 2022, Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities, Sci Rep, 12, 21938, 10.1038/s41598-022-26400-x Moghtaderi, 2022, Niosomes: a novel targeted drug delivery system for cancer, Med Oncol, 39, 240, 10.1007/s12032-022-01836-3 Yasamineh, 2022, A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system, Int J Pharm, 624, 121878, 10.1016/j.ijpharm.2022.121878 Brown, 2006, Dermal and transdermal drug delivery systems: current and future prospects, Drug Deliv, 13, 175, 10.1080/10717540500455975 Maheshwari, 2015, Chitosan encrusted nonionic surfactant based vesicular formulation for topical administration of ofloxacin, Sci Adv Mat, 7, 1163, 10.1166/sam.2015.2245 Elsana, 2019, Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems, Sci Rep, 9, 15120, 10.1038/s41598-019-51065-4 Kumar, 2011, Nonionic surfactant vesicular systems for effective drug delivery – an overview, Acta Pharm Sin B, 1, 208, 10.1016/j.apsb.2011.09.002 Sezgin-Bayindir, 2015, Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug, AAPS Pharm Sci Tech, 16, 108, 10.1208/s12249-014-0213-9 Rawal, 2021, Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer, Drug Deliv Transl Res, 11, 2030, 10.1007/s13346-020-00866-6 Pir Cakmak, 2019, Lipid vesicle-coated complex coacervates, Langmuir, 35, 7830, 10.1021/acs.langmuir.9b00213 Sankar, 2019, Formulation and characterization of liposomes containing clindamycin and green tea for anti acne, Res J Pharm Technol, 12, 5977, 10.5958/0974-360X.2019.01038.2 Londhe, 2022, Formulation, characterization, optimization and in-vivo evaluation of methazolamide liposomal in-situ gel for treating glaucoma, J Drug Deliv Sci Technol, 67, 102951, 10.1016/j.jddst.2021.102951 Saka, 2020, Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice, J Drug Deliv Sci Technol, 58, 101691, 10.1016/j.jddst.2020.101691 Aghdam, 2019, Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release, J Control Release, 315, 1, 10.1016/j.jconrel.2019.09.018 Jyothi, 2022, Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update, Int J Pharm, 624:122022 Pei, 2021, Daphnetin exerts an anticancer effect by attenuating the pro-inflammatory cytokines, J Biochem Mol Toxicol, 35, 1, 10.1002/jbt.22759 Forbes, 2014, Rapid, reversible release from thermosensitive liposomes triggered by near-infra-red light, Part Part Syst Charact, 31, 1158, 10.1002/ppsc.201400035 Maheshwari, 2012, Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment, Saudi Pharm J, 20, 161, 10.1016/j.jsps.2011.10.001 Song, 2021, ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis via inhibiting iRhom2/TNF-α/BAFF pathways, Nanoscale, 13, 20170, 10.1039/D1NR05518F Tatipamula, 2021, Phenolic compounds as antidiabetic, anti-inflammatory, and anticancer agents and improvement of their bioavailability by liposomes, Cell Biochem Function, 39, 926, 10.1002/cbf.3667